Retraction Volume 12, Issue 20 pp 20930
Retraction: miR-5089-5p suppresses castration-resistant prostate cancer resistance to enzalutamide and metastasis via miR-5089-5p/SPINK1/ MAPK/MMP9 signaling
- 1 Heilongjiang Key Laboratory of Scientific Research in Urology, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China
- 2 Department of Anesthesia, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, 150001, China
Received: September 8, 2020 Accepted: October 12, 2020 Published: October 31, 2020https://doi.org/10.18632/aging.104212
How to Cite
Copyright: © 2020 Wang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has been retracted: Authors concluded that the experimental results are not solid enough to support their conclusions. Thus, they have made the decision to retract the article upon the agreement of all listed authors.